NFE2L2 and non-small cell lung carcinoma: The plant-derived quassinoid brusatol inhibits the Nrf2 pathway by enhancing ubiquitination and degradation independent of KEAP1 and sensitized an NSCLC cell line to cisplatin treatment [212].